Data is not available at this time.
LANXESS AG is a Germany-based specialty chemicals company operating in four key segments: Advanced Intermediates, Specialty Additives, Consumer Protection, and Engineering Materials. The company serves diverse industries, including agrochemicals, automotive, construction, and electronics, with a focus on high-value chemical solutions. Its product portfolio spans intermediates, additives, flame retardants, and technical plastics, positioning it as a critical supplier for industrial and consumer applications. LANXESS leverages its long-standing expertise in chemical innovation to maintain a competitive edge in niche markets, particularly in Europe and globally. The company’s diversified revenue streams and strong R&D capabilities allow it to adapt to shifting demand in sectors like sustainable materials and water treatment. However, it faces intense competition from larger chemical conglomerates and regional players, requiring continuous investment in efficiency and differentiation. LANXESS’s market position is further influenced by regulatory pressures and raw material cost volatility, which impact profitability across its segments.
In FY 2023, LANXESS reported revenue of €6.37 billion but recorded a net loss of €177 million, reflecting margin pressures from elevated input costs and weaker demand in key markets. Operating cash flow stood at €508 million, supported by working capital management, while capital expenditures totaled €320 million, indicating ongoing investments in capacity and innovation. The diluted EPS of -€2.05 underscores near-term profitability challenges.
The company’s negative net income and EPS highlight earnings pressure, though its operating cash flow suggests underlying cash generation remains intact. Capital efficiency is strained by high debt levels (€3 billion) relative to cash reserves (€299 million), necessitating disciplined capital allocation. Segment performance varies, with Consumer Protection likely more resilient due to stable demand for hygiene and water treatment solutions.
LANXESS’s balance sheet shows €299 million in cash against €2.99 billion in total debt, indicating a leveraged position. The net debt-to-equity ratio suggests moderate financial risk, but liquidity depends on sustained cash flow generation. The company’s ability to manage debt maturities and invest in growth while maintaining credit metrics will be critical in the medium term.
Despite recent losses, LANXESS maintains a dividend of €0.10 per share, signaling commitment to shareholder returns. Growth prospects hinge on demand recovery in automotive and construction sectors, as well as innovation in sustainable chemicals. The company’s long-term strategy focuses on high-margin specialties, but cyclical end-market exposure may delay a full earnings rebound.
With a market cap of €4.85 billion and a beta of 1.61, LANXESS is viewed as a higher-risk play in chemicals, reflecting its cyclicality and operational challenges. Investors likely await margin improvement and debt reduction for a sustained re-rating, with current valuation factoring in near-term headwinds.
LANXESS’s strengths lie in its diversified specialty portfolio and technological expertise, particularly in sustainability-driven segments like water treatment and lightweight materials. However, macroeconomic uncertainty and pricing volatility pose risks. The outlook depends on execution in cost optimization and growth initiatives, with 2024 likely a transitional year toward improved profitability.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |